Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Total 13F shares
-
28,336,176
-
Share change
-
-6,947,541
-
Total reported value
-
$182,450,624
-
Put/Call ratio
-
48%
-
Price per share
-
$6.44
-
Number of holders
-
106
-
Value change
-
-$209,375,667
-
Number of buys
-
62
-
Number of sells
-
73
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2016
As of 31 Mar 2016 PTC THERAPEUTICS, INC. - Common Stock (PTCT) had 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 28,336,176 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Sectoral Asset Management Inc, VANGUARD GROUP INC, TOCQUEVILLE ASSET MANAGEMENT L.P., BlackRock Fund Advisors, BB BIOTECH AG, FMR LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, RENAISSANCE TECHNOLOGIES LLC, and Camber Capital Management LLC.
This table shows 106 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.